[1] BIFFI R, TORO A, POZZI S, et al. Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved?[J]. Support Care Cancer, 2014, 22(6):1705-1714. [2] TABATABAIE O, KASUMOVA G G, ESKANDER M F, et al. Totally implantable venous access devices: a review of complications and management strategies[J]. Am J Clin Oncol, 2017, 40(1):94-105. [3] ZHOU J, QIAN S K, HE W S, et al. Implanting totally implantable venous access port via the internal jugular vein guided by ultrasonography is feasible and safe in patients with breast cancer[J]. World J Surg Oncol, 2014, 12:378. [4] SOUSA B, FURLANETTO J, HUTKA M, et al. Central venous access in oncology: ESMO Clinical Practice Guidelines[J]. Ann Oncol, 2015, 26(suppl 5):v152-v168. [5] SAUGEL B, SCHULTE-UENTROP L, SCHEEREN T, et al. Ultrasound-guided central venous catheter placement: first things first[J]. Crit Care, 2017, 21(1):331. [6] YIN Y X, GAO W, LI X Y, et al.Randomized multicenter study on long-term complications of peripherally inserted central catheters positioned by electrocardiographic technique[J]. Phlebology, 2020, 35(8):614-622. [7] LIU Z, ZHENG X, ZHEN Y N, et al. Efficacy, safety, and cost-effectiveness of intracavitary electrocardiography-guided catheter tip placement for totally implantable venous access port[J]. Ann Vasc Surg, 2022, 83:168-175. |